Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nonsquamous Non-small-cell Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00021060
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung Cancer+3 more
National Cancer Institute (NCI) 842
Large-scale testing (Phase 3)Active Not RecruitingNCT06074588
What this trial is testing

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC 556
Large-scale testing (Phase 3)Active Not RecruitingNCT06305754
What this trial is testing

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC 550
Testing effectiveness (Phase 2)Active Not RecruitingNCT04736173
What this trial is testing

Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNonsquamous Non Small Cell Lung CancerSquamous Non Small Cell Lung Cancer+1 more
Arcus Biosciences, Inc. 169
Testing effectiveness (Phase 2)UnknownNCT03062800
What this trial is testing

Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)

Who this might be right for
Advanced Nsclc
Qilu Hospital of Shandong University 232
Not applicableStudy completedNCT02679443
What this trial is testing

Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy

Who this might be right for
Lung AdenocarcinomaNeutropeniaAnemia+2 more
Post Graduate Institute of Medical Education and Research, Chandigarh 161
Large-scale testing (Phase 3)Study completedNCT00762034
What this trial is testing

Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 939
Early research (Phase 1)Ended earlyNCT01373463
What this trial is testing

Cisplatin and Pemetrexed With Radiation Followed by Lobectomy

Who this might be right for
Nonsquamous Nonsmall Cell Neoplasm of LungNonsmall Cell Lung Cancer Stage III
Medical University of South Carolina 48
Large-scale testing (Phase 3)UnknownNCT01656551
What this trial is testing

MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIIB
National Cancer Institute, Naples 232
Testing effectiveness (Phase 2)Ended earlyNCT04265534
What this trial is testing

KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerNon-Squamous Non-Small Cell Neoplasm of Lung+3 more
Calithera Biosciences, Inc 40
Large-scale testing (Phase 3)Study completedNCT00806819
What this trial is testing

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 718
Testing effectiveness (Phase 2)Study completedNCT01160744
What this trial is testing

Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 280
Testing effectiveness (Phase 2)Active Not RecruitingNCT05403385
What this trial is testing

Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Metastatic NSCLC - Non-Small Cell Lung CancerLocally Advanced NSCLC - Non-Small Cell Lung Cancer
iTeos Therapeutics 36
Testing effectiveness (Phase 2)Study completedNCT01263782
What this trial is testing

BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 64
Large-scale testing (Phase 3)UnknownNCT03533127
What this trial is testing

LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNon Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer Recurrent
Luye Pharma Group Ltd. 648
Testing effectiveness (Phase 2)Ended earlyNCT02119650
What this trial is testing

Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Carcinoma)
Incyte Corporation 76
Not applicableEnded earlyNCT04474613
What this trial is testing

Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside Sites

Who this might be right for
Non Small Cell Lung Cancer
Case Comprehensive Cancer Center 26
Large-scale testing (Phase 3)Study completedNCT03950674
What this trial is testing

Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)-Japan Extension Study

Who this might be right for
Non-Small-Cell Lung Carcinoma
Merck Sharp & Dohme LLC 40
Testing effectiveness (Phase 2)Study completedNCT01473563
What this trial is testing

Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Nonsquamous Non-Small Cell Neoplasm of LungNon-Small Cell Lung Cancer MetastaticNon-Small Cell Lung Cancer Stage IIIB
Eli Lilly and Company 52
Large-scale testing (Phase 3)Active Not RecruitingNCT05973773
What this trial is testing

REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)

Who this might be right for
Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
Taiho Oncology, Inc. 285
Next Page